Fire Trucks Market is expected to drive market growth over the forecast period

The global fire trucks market is projected to reach USD 7.41 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for fire trucks owing to rising penetration in application segments, including residential & commercial, enterprises & airports, and military, is expected to drive market growth over the forecast period.

Growing infrastructure in the developing countries including India, China, South Korea coupled with increasing awareness regarding fire safety is expected to drive the demand for fire trucks over the next eight years. The demand in enterprises and airports for fire apparatus and increasing governmental regulations towards ensuring fire safety compliance is expected to be a contributing factor for market growth across the globe.

The market consists of raw material suppliers, manufacturers, distribution channels, and end user applications. The companies including Alexis Fire Equipment Co. and Xuzhou Handler Special Vehicle Co. Ltd. procure raw materials such as chassis and metal sheets required for manufacturing of fire trucks from the local suppliers, as it saves transportation costs. However, few companies including Gimaex International and Albert Ziegler GmbH purchase trucks instead of chassis from established truck manufacturers such as MAN and Scania, install the components and fire equipment, and sell them to the fire departments.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/fire-trucks-market

Further key findings from the study suggest:

• Residential & commercial application accounted for over 40% of the overall fire trucks market. Growing global population and resultant surge in building & construction activities have led the government to enforce stringent fire safety regulations across all sectors. This resulted in a significant increase in demand for fire trucks and is expected to drive market growth significantly over the forecast period.
• China demand for fire truck was valued at over USD 650 million in 2015. High production capacity coupled with inexpensive labor are expected to be the driving forces for rising demand and supply for fire trucks in the country. In addition, growing application in manufacturing sector and residential sector is expected to aid market growth in China.
• North America accounted for a large share of the market, and is expected to witness significant growth, growing at over 6% over the forecast period. Large number of fire stations and stringent regulations regarding fire safety are expected to be the key factors for market growth in the region.
• The market in Europe, Middle East & Africa (EMEA) is expected to grow at a CAGR of over 5%. Product innovation, coupled with technological advancements in the industry, is expected to be the drivers of the EMEA market. However, high import prices are expected to restrain fire trucks market growth in Middle East & Africa.
• Key players in the industry include Rosenbauer International AG, Oshkosh Corporation and Magirus GmbH. Auxiliary Power Unit is an idle-reduction technology designed by Rosenbauer International AG, specifically for use on fire apparatus; this is expected to save operating costs of endusers by a huge margin.

Anti-Counterfeit Pharmaceuticals and Cosmetics Packaging Market is expected to grow over the next six years

Global anti-counterfeit pharmaceuticals and cosmetics packaging market is expected to grow over the next six years owing to increasing rules and regulations and government initiatives to protect consumers from the use of harmful products.

Personal care and cosmetic products are the top priority targets for counterfeiters. Counterfeiting is more relevant in high-volume and low-value markets. The premium beauty products and personal care products have now become daily skin care products, which are available widely in local market. This has caused more counterfeiting of such consumables posing a need to design some stringent rules.

The International Trade Association (INTA) supports Anti-Counterfeiting Trade Agreement (ACTA), a guideline for the enforcement of trademark anti-counterfeiting. 

In September 2012, Japan was the first to sign this agreement. INTA along with International Chamber of Commerce’s Business Action has formed Business Response Group (BRG) to Stop Counterfeiting (BASCAP), so that national and international industries can comment and give suggestions for ACTA.

Pharmaceutical is not a centralized sector and, hence many small-scale players have started managing their own supply chains. Increasing counterfeiting has now led to track-and-trace technologies, which secure the original product verifying them with multi-layered authentic technologies.

Although premium product companies can afford trace-and-track technologies such as e-Pedigree and Radio Frequency Identification System (RFID), economic product companies use conventional methods such as holograms, dyes, and inks.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/anti-counterfeit-pharmaceuticals-cosmetics-packaging-market

The anti-counterfeiting market is segmented into technology, application, and region. Technologies include authentic packaging technologies such as ink and dyes, security inks, 

holograms, watermarks, and taggants. Other type of technology is called track-and-trace technology, which is the bar code technology and RFID technology. The RFID technology leads the market in the technology sector. This is attributed to the efficiency and effectiveness provided by it in tracking high-value products.

The application segment of the industry includes food packaging, pharmaceutical packaging, over the counter drugs, and prescription drugs. Increasing healthcare expenditure and government initiatives are expected to propel pharmaceutical packaging segment growth over the forecast period.

In September 2015, 4th Annual Pharma Anti-Counterfeiting is expected to take place in London. The key points to be discussed are government policies in EU and the U.S. for pharma 

anti-counterfeiting and product securities, developing strategies for using the latest technology throughout supply chain, including anti-counterfeiting in business plan, and many more topics to enhance knowledge and increase awareness among the industry players.

Geographical segments include North America, Europe Asia Pacific, Latin America, and MEA. In 2014, North America dominated the industry owing to the maximum pharmaceutical product innovations, a broad consumer durable market, and expensive healthcare costs. Pharmaceutical and cosmetic industry is projected to have maximum counterfeiting in Europe, therefore, making this region a lucrative regional segment.

Asia Pacific is expected to be the fastest growing market owing to the continuous support by the pharma companies organizing awareness campaigns and also rising level of awareness about authentic pharmaceutical drugs. In August 2015, Alibaba, a Chinese online retailer, offered counterfeit reporting in English. This enabled foreign customers to file complaints and place requests on its Tmall and Taobao e-commerce sight.

Major companies governing the anti-counterfeiting industry are Alien Technology Corp., Flint Group, InkSure Technologies, Honeywell, AlpVision, Sicapa, Avery Dennison, Authentix Inc., Impinj Incorporation, and Zebra Technologies.

In January 2014, Alien Technology introduced Glint ALN-9715, a footprint for tagging cosmetics, jewelry, and other metal-coated products. The Glint tag includes UHF antenna, which tags till 3 feet. In April 2014, Alien introduced two UHF passive RFID tags, Wonder Dog ALN-9768 and Higgs 4 IC near-field inlay.

Flint Group, headquartered in the U.S., inaugurated its new plant in India in January 2013. This enabled the company to reduce the delivery time and get closer to customers, especially in North and West India.

In October 2012, InkSure technology, which specializes in machine-readable anti-counterfeiting solutions, introduced high-security taggants approved by the FDA for direct contact foods. They have wide applications in protecting tobacco and alcohol products, keeping harmful products away from consumer use.

Fingerprint, a breakthrough product of AlpVision, is used to track mass-produced molding objects. In May 2012, Nolato Medical and AlpVision announced a partnership in order to protect primary pharmaceutical packaging and medical devices.

The strategic initiatives by various industry players to expand their industry share include complying with the agreements such as INTA and collaborations between manufacturers to provide cost-efficiency and economy of scale. All these factors are expected to enhance market growth over the forecast period.

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Contact Lenses Market is expected to drive market growth over the next six years

The global market for contact lenses is expected to reach USD 12.48 billion by 2020, according to a new study by Grand View Research, Inc. Expanding user base coupled with aging population is expected to drive market growth over the next six years. Grand View Research also observes that growing need for enhancing aesthetic appearance is expected to fuel demand for cosmetic contact lenses.

Increasing incidences of ophthalmic disorders including myopia, hypermetropia and astigmatism is expected to positively impact the global market over the forecast period. Additionally, changes in lifestyle and growing elderly population have enhanced market penetration for corrective as well as cosmetic contact lenses over the last three years. Growing acceptance of procedures including PRK and LASIK on a global level may hinder market growth over the next six years.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/contact-lenses-market

Further key findings from the study suggest:

• The global market was estimated to be 898.4 million units in 2013 and is expected to reach 1,132 million units by 2020, at an estimated CAGR of 3.4% from 2014 to 2020.
• Soft contact lenses dominated the market and accounted for over 88% of the global demand in 2013. Demand for daily disposable contact lenses is expected to continue increasing over the forecast period, due to benefits such as high level of hygiene and lowered risk of infections. Rigid gas permeable (RGP) contact lens demand is mainly on account of their use in orthokeratology (ortho-k), astigmatism and presbyopia.
• Spherical lenses are expected to continue leading the global market; the segment accounted for over 60% of the overall shipments in 2013. They are primarily prescribed for correcting disorders such as myopia and hypermetropia, and have a spherical surface. Multifocal contact lenses are expected to grow faster than the global average, driven by demand in treating presbyopia and other age-related ophthalmic ailments.
• Corrective contact lenses demand accounted for over 40% of the overall market share in 2013; it is further expected to remain the largest usage segment over the forecast period. Therapeutic contact lenses which are used to treat aphakia and for pain relief are also expected to account for considerable market share in the coming years.
• North America accounted for over 35% of the global demand in 2013, and is expected to remain the largest market over the next six years. Asia Pacific is estimated to be the fastest growing market, at an estimated CAGR of 3.9% from 2014 to 2020.
• Key industry participants include Johnson & Johnson, CIBA Vision, Bausch & Lomb, and CooperVision among others. Product innovation and portfolio enhancement are among the major growth strategies followed by these companies.

Medical Textiles Market is expected to reach USD 20.23 billion by 2022

The global medical textiles market is expected to reach USD 20.23 billion by 2022, according to a new report by Grand View Research, Inc. The rise in the number of elderly population, ongoing technological advancements and increase in health consciousness are fueling the growth of global medical textiles market.

Burgeoning health concerns necessitating the criticality of awareness for better healthcare practices coupled with rising disposable income are expected to augment the demand for medical textiles. Growing medical & hygiene sectors and health conscious population of the developing economies are projected to drive the demand for medical textiles market over the forecast period.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/medical-textiles-market

Further key findings from the study suggest:

• The non-woven segment is expected to grow at a CAGR of over 5.0% from 2015 to 2022. Nonwoven fabrics are used in the myriad of applications extending from wound dressings, adhesive tapes, cotton pads, disposable surgical clothing, bandages (simple bandages, light support bandages, orthopedic bandages). Rising application of these products in the healthcare sector is expected to drive market growth.
• Non-implantable goods accounted for over 30.0% share of the global medical textiles market. Increasing incidence of injuries is fueling the demand for medical textiles in non-implantable goods segment. Furthermore, increasing prevalence of diabetes and rising obesity are also propelling the growth of non-implantable goods segment over the forecast period.
• North America market is expected to grow at a CAGR of 4.4% from 2015 to 2022. North America and Europe is projected to continue its dominance jointly in medical textiles market through continuing to invest in research and development activities and identifying opportunities with expanding medical infrastructure.
• Demand for medical textiles in Europe was over USD 4.2 billion in 2014. Germany is a major country involved in the foreign trade of medical textiles. Similarly, Germany is also the second largest textile importing country after the U.S. and has developed as a lucrative market for many textile exporting countries since last three decades. Germany is Europe's leading location for medical technology and second biggest in terms of medical technology production and medical services provider across the globe.
• Biomedical Structures Inc. is a key player engaged in the manufacturing, advanced design and development of medical textiles for numerous device manufacturers in the general surgery, orthopedic, tissue engineering, cardiovascular and regenerative medicine markets. Key companies include Bally Ribbon Mills, Freudenberg & Co. KG, Vestagen Technical Textiles Inc, Bluestar Silicones International, ATEX Technologies, Inc. and Biomedical Structures, Inc.

Rising demand of Diabetic Retinopathy Market expansion over the estimated phase

Global Diabetic Retinopathy Market is expected to reach USD 10.11 billion by 2022, according to a new study by Grand View Research Inc. Diabetic retinopathy is considered as a serious sight threatening complication that results due to long term diabetes. The treatment line selection for diabetic retinopathy depends on the severity of the condition and may require intraocular injections, anti VEGF drugs, laser surgery or vitrectomy. Increasing incidences of diabetes, rising geriatric population base and the growing demand for early detection are some high impact rendering drivers of the diabetic retinopathy market. Furthermore, improving healthcare infrastructure, rising demand for cost-effective and safe treatment and rising focus of market players on emerging nations such as India and China are also anticipated to propel market growth. Presence of supportive government initiatives such as the Queen Elizabeth Diamond Jubilee Trust, which is taking initiatives for increasing patient awareness levels in order to promote regular retinal screening and early laser surgery to prevent permanent visual impairment and Ophthalmic Society of South Africa which works towards the improvement of reimbursement policies are anticipated to fuel the growth of the diabetic retinopathy market over the forecast period.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/diabetic-retinopathy-market

Further key findings from the study suggest:

• Anti VEGF is identified as the most attractive sub segment of the diabetic retinopathy market, growing at a rate of over 6.0% over the forecast period owing to, the rising incidences of diabetes and high efficacy rates
• The non proliferative diabetic retinopathy segment accounted for the largest market share in 2014. The growing geriatric population and rising incidences of blindness caused due to diabetes are some key factors accounting for its large share. Furthermore, the increasing demand for regular retinal screening for long time diabetic patients is also expected to boost segment growth.
• The North American diabetic retinopathy market accounted for over 35.0% of the revenue in 2014 on account of, the presence of high diagnostic and therapeutic rates in the U.S. The rising patient awareness levels and the presence of favorable government initiatives encouraging regular retinal screening is expected to drive regional market growth.
• The Asia Pacific diabetic retinopathy market is likely to witness lucrative growth over the forecast period due to, the presence of unmet needs in the developing economies such as China and India. Presence of favorable government initiatives to enhance retinal screening rates and improving healthcare infrastructure are also expected to contribute towards rapid market growth.
• Some key players of the diabetic retinopathy market include Bayer Healthcare, Novartis AG, ThromboGenics, Regeneron Pharmaceuticals Inc., Actavis Plc, Alimera Sciences, BCN Peptides and Kowa Group

Healthcare CRM Market is further anticipated to increase the market growth in coming years

The global healthcare CRM market is expected to reach USD 17.4 billion by 2025, according to a new study by Grand View Research Inc. Rising demand for workflow automation and single platform for tracking medical information provides coordination of patient care, service and timely delivery which is expected to drive the industry growth.

The healthcare payers, providers and life science companies also need better integration between their administration and patient queries which is further anticipated to increase the market growth. The healthcare payers, providers and life science companies also need better integration between their administration and patient queries which is further anticipated to increase the market growth.

Gathering information about target customers, marketing effectiveness, sales, feedback and market needs facilitates the workflow automation within the organization which is another vital factor leading towards the growth of the healthcare customer relationship management market. Moreover, technological advancements in cloud CRM, mobile CRM and social CRM provides effective communication medium which is expected to further accelerate healthcare customer relationship management industry growth.

Gathering information about target customers, marketing effectiveness, sales, feedback and market needs facilitates the workflow automation within the organization which is another vital factor leading towards the growth of the healthcare CRM market. Moreover, technological advancements in cloud CRM, mobile CRM and social CRM provides effective communication medium which is expected to further accelerate healthcare CRM industry growth.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/crm-in-healthcare-market

Further key findings from the study suggest:

• Cloud CRM is identified as the largest technology segment used as platform for the healthcare CRM industry owing to, rising need for accessing the software from different devices and locations.
• Mobile customer relationship management segment is expected to be the fastest growing technology segment with a lucrative CAGR over the forecast period.
• Hybrid of individual and referral CRM system is expected to be the largest product segment by 2025 owing to the advantages of both the models in getting access to sensitive patient information.
• Referral healthcare CRM is expected to be the fastest growing product segment over the forecast period.
• Key market players for healthcare CRM include IBM, salesforce.com, Veeva Systems, Siemens Healthcare, SAP, Accenture, Oracle, Microsoft, Amdocs Ltd., Anthelio Healthcare Solutions, AllScripts Healthcare Solutions Inc., NetSuite, Cerner, Nice systems, Talisma, Lawson and Verint Systems.

Negative Pressure Wound Therapy Market is fastest growing segment over the forecast period

The global negative pressure wound therapy (NPWT) market is anticipated to reach a value of USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc. Increasing awareness in the developing regions pertaining to advanced wound care is providing a significant opportunity to the key market players to cater to the unmet needs of the target population. The primary driver associated with this market is the cost-effectiveness of single-use negative pressure wound therapy devices.

Major companies are also focusing on education of reimbursement coveragein such regions to further increase the affordability of these devices. However, the current reimbursement policies mostly cover conventional NPWT devices owing to their high cost.Furthermore, the geriatric population is also contributing to a great extent toward increasing the prevalence of chronic diseases. Increasing age is one of the high risk factorsleading to the development of chronic diseases such as atherosclerosis, which is one of the prime cardiovascular disorders prevalent in the geriatric population.

NPWT is one of the commonly accepted therapies employed for the treatment of arterial ulcers, which is one of the major complications of atherosclerosis. Around 50% of the people worldwide are exposed to fire-related traumas, among which, 90% of the cases occur in low to moderate income countries.Thus, the rising incidence of traumatic events is expected toengender a high demand for negative pressure wound therapy products.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/negative-pressure-wound-therapy-npwt-market

Further key findings from the study suggest:

• Conventional NPWT devices dominated the product segment in 2015 owing to their high cost and availability of favorable reimbursement policies
• Single-use negative pressure wound therapy devices segment is considered to be the fastest growing segment over the forecast period
• Diabetic foot ulcer held the largest revenue share in 2015 owing to its numerous applications,thus yielding a high success rate using NPWT
• Homecare setting is anticipated to witness an attractive CAGR over the forecast period owing to the emerging applicability of single-use NPWT devices in the homecare setting and cost-effectiveness of the therapy
• North America dominated the overall NPWT market in 2015. This is primarily due to the increased usage of the target therapy in this region, which has led to a reduction in hospital stays and contributed toward enhanced quality of patient lives
• Some key companies in this market are Acelity L.P. Inc., Smith & Nephew, Mölnlycke Health Care, Talley Group Limited, ConvaTec Inc., Devon Medical, Cardinal Health, Inc., DeRoyal Industries, Inc., Medela AG and Paul Hartmann AG

Powder Coatings Equipment Market is expected to witness significant growth over the forecast period

The global powder coatings equipment market is expected to reach USD 2.14 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to witness significant gains over the forecast period on account of increasing usage of powder coatings in automotive, consumer goods, architectural, furniture, general industries and defense applications.

Rising demand for furniture and other architectural products such as windows and aluminum extrusions are expected to increase the industry size over the next eight years. Manufacturers are offering coatings booth made up of 18-gauge galvanized metal, for improving durability as well as reduce costs associated with installation.

Powder coat guns are expected to witness significant growth at a CAGR of 7.5% owing to its benefits including lightweight and easy color change. Furthermore, consumption of guns for spraying of powder coatings on metals, ceramics, glass and plastic surfaces is likely to augment demand over the upcoming years.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/powder-coatings-equipment-market

Further key findings from the study suggest:

• Automotive accounted for 20.8% of the overall industry share in 2015 and is likely to witness the fastest growth over the forecast period. This trend is expected to continue on account of rising requirements of powder coatings for a broad range of applications including bodywork, trim, aluminum wheels, and in-mold light weight components.
• The presence of various automotive players including Ford, General Motors, Chevrolet, Mercedes-Benz and Dodge is expected to fuel the product demand over the upcoming years.
• MEA accounted for 5% of the global share in 2015 and is projected to witness gains in light of the growth of the construction sector especially in Qatar and UAE. Furthermore, this scenario is likely to be supported due to certain factors such as advanced real estate regulatory framework, economic recovery, and increasing infrastructure project in the region.
• The market is fragmented in nature with a large number of players present in the U.S., Switzerland, and India. Key players include Nordson Corporation, Gema Switzerland GmbH, WAGNER, Parker Ionics, Red Line Industries Limited, Reliant Finishing Systems, Carlisle, Hangzhou Color and Oven Empire Manufacturing.
• Companies are focusing on product innovation to increase their presence in the global market. For instance, in October 2016, Gema Switzerland GmbH launched MultiColor Super-fast color change solution that maximizes the flexibility and productivity of the coatings line and avoids idle times.
• In November 2013, Nordson Corporation launched Encore HD Automatic Powder Spray Gun which is “softer” and offers even charged powder cloud for optimum transfer efficiency.
• Development of new glass booth coupled with ongoing product innovation to increase durability and reduce associated cost will propel equipment growth. Furthermore, growing DIY equipment will create immense market potential over the forecast period.

Key factors driving the Multiple Myeloma Therapeutics Market growth over the forecast period

The global multiple myeloma therapeutics market was valued at USD 7.5 billion in 2015 and is expected to reach a value of USD 37.5 billion by 2024. Key factors driving the market expansion include constant introduction of newer and effective therapeutic options and high adoption rates of the same.

This space is expected to gain momentum with the addition of novel drugs to the current therapeutics array with monoclonal antibodies and Histone Deacetylase (HDAC) inhibitors. Due to failed outcomes of the currently available medication, there is a high demand for effective treatment strategies to offset therapeutic dissatis faction and increase life expectancies of patients; which in turn is expected to boost the research and development of improved therapies for multiple myeloma.

Growing prevalence of the disease along with the surging elderly population is the prime factor expected to drive the growth significantly during the forecast period. Complications involved in treating geriatric patients are driving the demand for supportive treatments such as restoration procedures involving transfusion of blood components and point of care technologies.

The U.S, followed by Europe, has been dominating the market owing to the presence of major players in these regions, faster approval rates, and favorable healthcare policies. Higher prevalence of multiple myeloma in the developed economies is a pivotal determinant driving the growth of the Europe market.

The space consists of a few major players including Celgene Corporation, Janssen Biotech, Inc., Bristol-Myers Squibb Company, and Novartis AG. A large revenue share is captured by Celgene Corporation with its high-performing drug, Revlimid. The drug currently dominates the market with more than 50% share of the total multiple myeloma therapeutics market.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/multiple-myeloma-therapeutics-market

Further key findings from the study suggest:

• According to the National Cancer Institute, more than 30,330 new cases of multiple myelomaare expected to register in 2016. The number of new cases is expected to grow each year with the growing geriatric population.
• Newly introduced drugs are expected to increase the longevity of patients undergoing treatment for multiple myeloma, which yields a high cumulative number of patients requiring treatment each year.
• In 2015, the chemotherapy and other drugs segment dominated the global space with largest revenue share owing to lack of effective alternative option.
• Chemotherapy and other drugs segment has been sub-segmented into traditional chemotherapy, immunomodulating agents, protea some inhibitors, HDAC inhibitors, and monoclonal antibodies.
• In 2015, immunomodulating agents drug class captured the largest market share. Absence of comparable alternatives is the prime factor driving the growth of the segment
• The newly introduced drugs belonging to the classes HDAC inhibitors and monoclonal antibodies are expected to show the fastest growth during the forecast period owing to the effectiveness and safety of these drugs

Ceramic Tiles Market is rising demand for new avenues in Asia Pacific over the forecast period

Global Ceramic Tiles Market is expected to reach USD 125.32 billion by 2020, according to a new study by Grand View Research, Inc. Construction industry growth in BRICS coupled with rising demand for new residential structures in emerging markets of China and India due to urbanization is expected to drive market demand for ceramic tiles over the forecast period. Stringent environment regulations pertaining to carbon emissions caused during the production of ceramic tiles has forced market players to increase their R&D expenditure on eco-friendly products, which is likely to open new market avenues in the near future.

Residential replacement was the largest application, accounting for more than 50% of market volume in 2013. Growing demand for durable material coupled with rising awareness towards personal hygiene is expected to augment ceramic tiles demand in residential replacement over the forecast period.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/ceramic-tiles-market

Further key findings from the study suggest:

• Global ceramic tiles market demand was 12,328.3 million square meters in 2013 and is expected to reach 21,822.7 million square meters by 2020, growing at a CAGR of 8.5% from 2014 to 2020.
• Floor tiles were the largest product segment for ceramic tiles market, accounting for over 50% of market volume in 2013. Emergence of floor tiles as a replacement for hardwood and other flooring options on account of superior properties such as high durability, frost & thermal shock resistance is expected to have a positive impact on ceramic tiles market in the near future.
• Asia Pacific was the largest ceramic tiles market, exceeding 60% of global volume in 2013. Government of India and China have increased spending on infrastructure improvement, which is expected to promote the demand for residential and commercial structures and boost ceramic tiles market over the forecast period.
• Emergence of West Africa as a manufacturing hub for ceramic industry on account of growing domestic demand for ceramics in household and building applications in countries such as Nigeria is expected to have a positive impact on market. Low manufacturing cost as compared to countries of North America and Europe has forced numerous ceramic manufacturers to commence production in West Africa. In December 2013, West African Ceramics Ltd. (WACL) announced an investment of over USD 50 million to commence production of ceramic tiles in Nigeria.
• Global ceramic tiles market is fragmented in nature due to presence of numerous companies operating across the world. Key market participants include Crossville Inc., Saloni Ceramica, and China Ceramics.

Ultrasound Device Market is expected to maintain its dominance throughout the forecast period

The global ultrasound device market is expected to reach USD 11.1 billion by 2024, according to a new report published by Grand View Research, Inc. Major drivers of the sonography market include expanding applications of the technique in therapeutic areas and government recommendations for periodic ultrasound screenings of the breast for breast cancer. 

High Intensity Focused Ultrasound (HIFU) is widely used for the treatment of prostate cancer. HIFU has lesser side effects for prostate cancer than the other available treatments. The other use of ultrasound technique for therapeutic purpose includes treatment of kidney stones and gallstones using extracorporeal shockwave lithotripsy (ESWL). 

2D, 3D/4D and Doppler ultrasound techniques are widely used in diagnostic imaging. 2D ultrasound segment captured the largest market share owing to the wide use of this technique in brain tumor and fetal screening. Most of the hospitals and healthcare facilities in developing countries offer 2D ultrasound as the device cost is relatively lesser and results in increasing the affordability of ultrasound imaging to patients. Along with 3D, 4D sonography has also become popular in obstetrics areas as it provides real-time movements of the fetus. 

Intensifying competition in the private sector has triggered advancements of the latest medical devices in private hospitals. As a result, demand for handheld imaging devices is swiftly increasing. In addition, the shifting trend to home healthcare and remote patient monitoring is augmenting the adoption of handheld devices. However, the demand for relatively bigger cart/trolley-based devices is escalating with the rising adoption of therapeutic ultrasound, where heavy hardware and large display screens are necessary.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/ultrasound-device-market

Further key findings from the study suggest:

• The diagnostic ultrasound devices segment captured a market share of 35.80% in 2015. The share of the segment was mainly attributed to government recommendations for routine checkups using ultrasound devices.
• The rising birth rates and in-vitro fertilization treatments are supporting the growth of the diagnostic ultrasound imaging segment as the imaging technique is widely accepted for fetal monitoring during pregnancy
• The handheld device segment is expected to exhibit the fastest growth during the forecast period owing to the convenience of portability, affordable price, and user-friendly technologies embedded in these devices
• North America captured the largest market share of 24.85% in 2015 and is expected to maintain its dominance throughout the forecast period. The presence of a well-defined regulatory framework, recommendations of government and healthcare agencies, and high adoption of remote patient monitoring and home healthcare services are the major factors supporting the market growth.
• Asia Pacific is anticipated to witness the fastest growth of 9.6% during the forecast period. Rising disposable income, growing awareness, and booming medical tourism industry are some of the factors expected to drive the Asia Pacific market towards swift growth during the forecast period.
• The ultrasound market is fragmented with the presence of many local players. Thus, market players are adopting strategies such as mergers and acquisitions and distribution partnerships to expand their market share and sustain the competition.
• Some key players contributing to this market include Toshiba Medical Systems Corporation, SonaCare Medical, Analogic Corporation, GE Healthcare, Philips Healthcare, Siemens Healthcare, Hitachi Medical Corporation, Samsung Medison, and Mindray Medical International Limited

Enzymes Market is expected to propel industry growth in the near future

The global enzymes market is expected to reach USD 17.50 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for enzymes in food & beverage products as they improve quality and eliminate deficiencies in the products is expected to propel industry growth in the near future.

Increasing demand for bioethanol and biodiesel in emerging economies including India, Brazil, and Thailand will augment industry growth over the forecast period. Growing number of government investments along with R&D activities in industrial enzymes will drive demand over the next eight years.

Rising population along with rising living standard will drive processed foods demand, which in turn will stimulate industry expansion. In addition, emerging protein design algorithms, along with growing inexpensive DNA sequencing technology will open new market avenues over the next seven years.

Carbohydrases accounted for 47.7% of the global market share in 2015, dominating the enzymes industry and the segment is expected to show significant growth in light of high usage in animal feed, textile, food & beverages, and pharmaceutical applications. Moreover, mounting usage of artificial sweeteners, prebiotic products, and juices is expected to fuel product demand over the forecast period.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/enzymes-industry

Further key findings from the study suggest:

• Specialty enzymes are anticipated to witness the fastest growth at a CAGR of 9.2% from 2016 to 2024 on account of increasing awareness regarding therapies for chronic diseases, along with growing incidences of digestive enzyme disorders. Moreover, increasing usage of the ingredient for diagnostic solutions is expected to augment growth. Chemical reactions in research & biotechnology are accelerated by making the use of enzymes. They also optimize the yield of the production processes, which is expected to bolster demand over the forecast period.
• Animal feed is likely to witness significant growth at a CAGR of 9.0% from 2016 to 2024 as a result of mounting demand for swine, bovine, poultry and aquaculture species. Growing global meat production coupled with rising health concern regarding meat quality will augment animal feed demand, which is expected to stimulate industry expansion.
• North America enzymes market was valued at USD 3.59 billion in 2015 and will show high gains in light of favorable government policies along with a robust manufacturing base in the U.S. Growing demand for animal feed and biofuels in the U.S. is expected to drive market size.
• Latin America accounted for 8.3% of the overall enzymes market and will show substantial growth in light of rapid industrialization coupled with increasing biodiesel production in Brazil and Argentina.
• Key industry players include Novozymes, Danisco, Royal DSM, BASF SE, DuPont, Lonza Group, and Advanced Enzymes Technologies Ltd. In January 2014, DuPont launched LAMINEX MaxFlow 4G enzyme, intended for increasing texture, taste and appearance of beer in beverages applications.

Nuclear Medicine Market is anticipated to drive the demand over the estimated phase

The nuclear medicine market is expected to reach USD 13.8 billion by 2024, according to a new report by Grand View Research, Inc. The burden of chronic diseases such as cancer and cardiac disorders is on rise. Nuclear medicine products are widely used for diagnosis as well as treatment of cancerous and cardiovascular disease.

The increasing prevalence of these disorders poses direct impact on usage of radiopharmaceutical market. For instance, as per the data published by the World Health Organization (WHO), the incidences of cancer are anticipated to increase by 70.0% which is further anticipated to drive the demand for radiopharmaceuticals.

The diagnostics when combined with nuclear medicine improve on accuracy. The accuracy in the diagnosis has a direct impact on the decision-making and treatment monitoring process. Adoption of PET as a diagnostic tool is rapidly increasing since it has high accuracy over other diagnostic techniques.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/nuclear-medicines-market

Further key findings from the study suggest:

• The product segments of nuclear medicine are divided into diagnostic and therapeutic. Diagnostic products held commanding share in 2015, this can be attributed to the advancements in scanning technologies.
• Therapeutic products such as Alpha Emitters, Beta Emitters and Brachytherapy are anticipated to exhibit lucrative growth.
• The key diagnostic application areas of nuclear medicine formed the largest market in 2015. These applications are in cardiology, neurology, oncology, and thyroid.
• North America owing to well-planned policies, reimbursement structure, high healthcare spending and increasing awareness dominated global nuclear medicine market in 2015.
• Asia Pacific is expected to witness lucrative growth in coming eight years. Increasing per capita income and reform in policies is favoring market players in terms of ease of doing business.
• The players in the nuclear medicine industry include Eckert & Ziegler Group, Mallinckrodt Pharmaceuticals, GE Healthcare, Jubilant Life Sciences, Bracco Imaging S.p.A, Nordion, Inc.

Asia Pacific is expected to increase Healthcare Predictive Analytics Market over the forecast period

The global healthcare predictive analytics market is expected to reach USD 19.5 billion by 2025, according to a new report by Grand View Research, Inc. Healthcare costs are increasing day by day and are anticipated to increase further. For instance, as per the IBM Global Business Services executive report in 2014, the per capita health expenditure of the U.S. was around USD 9,400 which was almost 2.4 times greater than the global average.

Government authorities, health organizations, and private players are striving to bring down health-care expenditure. Healthcare predictive analytics helps in bending the cost curve through optimization of the existing clinical workflow, operations, and payment strategies.

With the advent of IoT in health-care and wearable technology, people are more aware of the available health metrics monitoring platforms and choose to closely monitor health parameters. This phenomenon is generating huge amount of patient data inclusive of diet habits, physiological parameters, and vital signs. Predictive modeling based on this data helps in understanding disease patterns using statistical tools to draw an analysis of key therapy trends and outcomes.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/healthcare-predictive-analytics-market

Further key findings from the study suggest:

• Financial applications of healthcare predictive analytics held a significant share of around 30.0% in 2015. Revenue cycle management and fraud detection are key financial applications.
• Increasing focus on population health management makes it one of the most lucrative growing application segments of the health-care predictive analytics market
• Payers form the key end-user segment of this market. Various insurance companies, health plan sponsors, and third party payers are other users of predictive.
• The usage of predictive analytics amongst payers such as hospitals, clinics, and physicians is anticipated to increase over the forecast period
• North America, being a pioneer in health-care IT technologies, dominated the global health-care predictive analytics market. Available advanced infrastructure with ample resources contributed to its dominance.
• Asia Pacific is expected to witness remunerative growth over the forecast period. Economic reforms, bolstering IT industry, and low operating costs are the key factors alluring market players to invest in this region.
• Some of the key players in this space include IBM, Cerner Corporation, Verisk Analytics, Inc., McKesson Corporation, SAS, Oracle, Allscripts, Optum, Inc.and MedeAnalytics, Inc. New product launches and collaborations are the key strategic under takings amongst the sector participants.

Rising of Steam Turbine Market is expected to significantly boost the system efficiency

The global steam turbine market is expected to reach USD 15.48 billion by 2025, according to a new report by Grand View Research, Inc. Steam turbines have been a key part of the global power generation systems from past. However, factors such as limited primary energy sources, increasing awareness regarding environmental pollution, etc. has resulted in rising need towards developing efficient steam turbines.

Steam turbines are now popularly used for combined heat & power (CHP) systems, mainly employed in industrial applications. CHP units offer greater efficiency & flexible output and also operate on cleaner fuels such as natural gas. Legislative support towards CHP installation is expected to foster small and medium capacity steam turbines demand over the forecast period.

The performance of the steam turbine greatly influences the overall efficiency, and for the same, market participants focus on improving the turbine efficiency. Companies such as GE have implemented a number of programs focusing on material development. Re-heat technology is another aspect which GE has revealed to have achieved a break through. The company is also working on double re-heat technology which is expected to significantly boost the system efficiency.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/steam-turbine-market

Further key findings from the study suggest:

• The global steam turbine market capacity was 103.16 GW in 2015 and is expected to reach 121.27 GW, growing at a CAGR of 1.6% from 2016 to 2025
• Steam turbines with <120 MW capacity is expected to be the fastest growing segment on account of increasing demand for small capacity CHP units
• Power & Utilities is expected to emerge as the largest application segment and accounted for over 70% of total capacity in 2015
• Industrial application segment is expected to witness the highest growth of 3.3% in terms of revenue over the forecast period
• Asia Pacific was the leading regional market with capacity share exceeding 50% in 2015
• Asia Pacific is also expected to witness the fastest growth of 3.2% over the forecast period owing to rapid industrialization and increasing focus on thermal power plants to fulfill increasing electricity demand.
• Siemens is expected to emerge as the largest player in the industry and is anticipated to hold over 20% of the market share
• Other companies operating in the market space include General Electric Co., Mitsubishi Heavy Industries Ltd., Toshiba, Ansaldo, Hitachi, Dresser-Rand

Aprotic Solvents Market is projected to propel the growth of market over the forecast period

The global aprotic solvents market is projected to reach USD 21.79 Billion by 2025, according to a new report by Grand View Research, Inc. growing pharmaceuticals industry is expected to drive the market over the forecast period.

In 2015, toluene dominated the product segment courtesy growing demand from end-use industries such as paints & coatings and construction. Toluene is also used in the manufacturing of benzene, an aprotic solvent, which has applications in the oil & gas and pharmaceutical industries. The growth of these industries, in turn, is projected to propel the growth of the toluene market over the forecast period.

The oil & gas sector dominated the application segment in 2015. This sector accounted for more than 30% in terms of value, in 2015. Growing demand for fossil fuels and petrochemicals is expected to drive the market in this segment, over the forecast period.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/aprotic-solvents-market

Further key findings from the study suggest:

• N-Methyl-2-pyrrolidone (NMP) is projected to grow at the highest CAGR of more than 5% from 2016 to 2025. This product can be used for dissolving various materials due to its excellent solvency properties, which has resulted in growing demand from the oil & gas industry.
• Among applications, the pharmaceuticals sector is projected to grow at the highest CAGR of 4.5% from 2016 to 2025. Growing consumption of bio-based solvents in this industry has resulted in high market demand. Stringent regulations against degradation of the environment due to extensive use of these chemicals have further increased the demand for bio-based solvents.
• Asia Pacific accounted for the highest share of over 40% in terms of value, in 2015.Growing paints & coatings and pharmaceuticals industries are expected to play key roles in the market growth. Besides, growing demand from the electronics industry is also expected to boost the market.
• The market in Central & South America is projected to grow at the second highest CAGR of 3.7% from 2016 to 2025. Emerging countries such as Brazil, Argentina, Chile, and Colombia are expected to be at the forefront of the growth in this region.
• The MEA region is also projected to grow at a steady CAGR from 2016 to 2025. The oil and gas industry in this region is expected to witness increased demand for aprotic solvents over the forecast period.
• Eastman Chemical Company, INEOS, BASF SE, and Du Pont are the major global players in the market. Some of the other prominent players include CNPC Jilin Chemical Group, Asahi Kasei, AlzChem AG, Shell Chemicals, Imperial Chemical Corporation, Mitsubishi Chemicals, Ashland, and Nanjing Jinlong.
• Mergers & acquisitions were one of the major development strategies adopted by these players from 2011 to 2016. In June 2014, INEOS completed the acquisition of Sasol Solvents Germany GmbH.This acquisition helped the company add to its product portfolio and consolidate its position in the European aprotic solvents market.